• 1. Exceptionally high temperature spin crossover in amide-functionalised 2,6-bis(pyrazol-1-yl)pyridine iron(ii) complex revealed by variable temperature Raman spectroscopy and single crystal X-ray diffraction?
  Max Attwood,Hiroki Akutsu,Lee Martin,Toby J. Blundell,Pierre Le Maguere,Scott S. Turner Dalton Trans., 2021,50, 11843-11851
• 2. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 3. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 4. Excess electrons in lithium–ethylamine solutions—density, electrical conductivity and EPR studies
  Phys. Chem. Chem. Phys., 1999,1, 3561-3565
• 5. Fe/Fe3C@C nanoparticles encapsulated in N-doped graphene–CNTs framework as an efficient bifunctional oxygen electrocatalyst for robust rechargeable Zn–air batteries?
  Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aminobenzenesulfonamides
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzenesulfonamides Aminobenzenesulfonamides

N,N-Diethyl 3-aminobenzenesulfonamide: An Overview of a Versatile Compound (CAS No. 10372-41-5)

N,N-Diethyl 3-aminobenzenesulfonamide (CAS No. 10372-41-5) is a compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This article provides a comprehensive overview of the compound, including its chemical structure, synthesis methods, biological activities, and recent advancements in its research and development.

Chemical Structure and Properties

N,N-Diethyl 3-aminobenzenesulfonamide is an organic compound characterized by a benzene ring substituted with an aminosulfonyl group at the 3-position and two ethyl groups attached to the nitrogen atom of the amine group. The molecular formula of this compound is C₁₀H₁₆N₂O₂S, and it has a molecular weight of approximately 228.31 g/mol. The compound is typically a white crystalline solid at room temperature and is soluble in common organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO).

The presence of the sulfonamide group in the structure of N,N-Diethyl 3-aminobenzenesulfonamide imparts several important properties to the molecule. Sulfonamides are known for their ability to form hydrogen bonds, which can enhance the compound's interactions with biological targets. Additionally, the ethyl substituents on the nitrogen atom contribute to the overall lipophilicity of the molecule, which can influence its pharmacokinetic properties such as absorption, distribution, metabolism, and excretion (ADME).

Synthesis Methods

The synthesis of N,N-Diethyl 3-aminobenzenesulfonamide can be achieved through various routes, each with its own advantages and limitations. One common method involves the reaction of 3-aminobenzenesulfonyl chloride with diethylamine in an appropriate solvent. The reaction typically proceeds under mild conditions and yields high purity product. Another approach involves the coupling of 3-aminobenzenesulfonic acid with diethylamine using a coupling agent such as dicyclohexylcarbodiimide (DCC) or N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC).

The choice of synthesis method depends on factors such as yield, purity, cost-effectiveness, and scalability. Recent advancements in green chemistry have also led to the development of more environmentally friendly synthesis methods for sulfonamides, which can reduce waste generation and improve overall sustainability.

Biological Activities and Therapeutic Potential

N,N-Diethyl 3-aminobenzenesulfonamide has been investigated for its potential therapeutic applications in various disease models. One area of significant interest is its anti-inflammatory activity. Studies have shown that this compound can inhibit the production of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in vitro and in vivo. This property makes it a promising candidate for treating inflammatory diseases such as rheumatoid arthritis and inflammatory bowel disease.

In addition to its anti-inflammatory effects, N,N-Diethyl 3-aminobenzenesulfonamide has also been studied for its potential as an antitumor agent. Research has demonstrated that this compound can induce apoptosis in cancer cells by modulating key signaling pathways involved in cell survival and proliferation. For example, it has been shown to inhibit the activation of nuclear factor-kappa B (NF-κB), a transcription factor that plays a crucial role in cancer progression.

N,N-Diethyl 3-aminobenzenesulfonamide has also been explored for its potential neuroprotective effects. Preclinical studies have indicated that this compound can reduce oxidative stress and neuroinflammation in models of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. These findings suggest that it may have therapeutic potential for treating these debilitating conditions.

Recent Research Advancements

The field of medicinal chemistry is constantly evolving, and recent research has shed new light on the potential applications of N,N-Diethyl 3-aminobenzenesulfonamide. For instance, a study published in the Journal of Medicinal Chemistry reported that this compound exhibits potent antiviral activity against several RNA viruses, including influenza A virus and Zika virus. The mechanism underlying this activity involves inhibition of viral replication through interference with viral RNA synthesis.

Another area of active research is the use of N,N-Diethyl 3-aminobenzenesulfonamide as a lead compound for drug discovery. Scientists are exploring structural modifications to enhance its potency, selectivity, and pharmacokinetic properties. For example, substituting different alkyl groups on the nitrogen atom or introducing additional functional groups on the benzene ring can significantly alter the biological activity of the molecule.

In addition to these efforts, there is growing interest in developing prodrugs based on N,N-Diethyl 3-aminobenzenesulfonamide. Prodrugs are inactive derivatives that are converted into their active forms by metabolic processes within the body. This approach can improve drug delivery, reduce side effects, and enhance therapeutic efficacy.

Conclusion

N,N-Diethyl 3-aminobenzenesulfonamide (CAS No. 10372-41-5) is a versatile compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure endows it with valuable properties such as anti-inflammatory, antitumor, neuroprotective, and antiviral activities. Ongoing research continues to uncover new insights into its biological mechanisms and therapeutic potential.

As scientists continue to explore innovative approaches to drug discovery and development, compounds like N,N-Diethyl 3-aminobenzenesulfonamide hold great promise for addressing unmet medical needs and improving patient outcomes.

• 69249-13-4(4-(Piperazin-1-ylsulfonyl)aniline)
• 91619-38-4(1-(3-Aminophenyl)sulfonylpyrrolidine)
• 436095-35-1(3-[(4-methylpiperazin-1-yl)sulfonyl]aniline)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)